Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Valvular Heart Disease

Free Subscription 22.09.2025 6 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 1 Circ Cardiovasc Interv 1 Circ Heart Fail 1 Heart 1 Int J Cardiol 1 J Am Soc Echocardiogr

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Catheter Cardiovasc Interv

1. OLIVA OA, Criscione E, Casenghi M, Lulic D, et al
   The NavigIIster: Transcatheter Aortic Valve Implantation With the Navitor Platform in Bicuspid Anatomy.
   Catheter Cardiovasc Interv. 2025 Sep 17. doi: 10.1002/ccd.70186.
   PubMed         Abstract available
   
   
2. OGAMI T, Hasan I, Phillippi JA, Serna-Gallegos D, et al
   Are Women at Higher Risk for Isolated Surgical Aortic Valve Replacement? Results From 178,000 STS Adult Cardiac Surgery Database Patients.
   Catheter Cardiovasc Interv. 2025 Sep 15. doi: 10.1002/ccd.70188.
   PubMed         Abstract available
   
   
3. XIA F, Chen X, Weng Z, Pan X, et al
   Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self-Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database-NTCVR.
   Catheter Cardiovasc Interv. 2025 Sep 15. doi: 10.1002/ccd.70183.
   PubMed         Abstract available
   
   
4. GHAFFAR G
   Letter to Editor: Balloon-Expandable Versus Self-Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry.
   Catheter Cardiovasc Interv. 2025 Sep 15. doi: 10.1002/ccd.70192.
   PubMed        
   
   
5. SEDRAKYAN S, Nikolaeva M, Bhat T, Khan F, et al
   Temporal Changes in Transvalvular Pressure Gradients in Balloon-Expandable and Self-Expanding Transcatheter Aortic Valves.
   Catheter Cardiovasc Interv. 2025 Sep 14. doi: 10.1002/ccd.70164.
   PubMed         Abstract available
   
   
6. HABERMAN D, Chaturvedi A, Lupu L, Chitturi KR, et al
   Hemodynamic Evaluation of Concomitant Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy With Pressure Wire.
   Catheter Cardiovasc Interv. 2025 Sep 14. doi: 10.1002/ccd.70143.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

7. WONG LN, Chan HT, Chan TH, Hui WH, et al
   Platypnea-Orthodeoxia Syndrome After Transcatheter Aortic Valve Implantation.
   Circ Cardiovasc Imaging. 2025 Sep 17:e018495.
   PubMed        
   
   

   
   Circ Cardiovasc Interv

8. MORRAY BH, Gillespie MJ, Cheatham JP, Salavitabar A, et al
   Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients.
   Circ Cardiovasc Interv. 2025 Jul 16:e015196.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

9. OCHALA J, Feng M, Wang Q, Chaami C, et al
   Heterogeneous Dysregulation of Myosin Super-Relaxation and Energetics in Hypertrophic Cardiomyopathy.
   Circ Heart Fail. 2025;18:e012614.
   PubMed         Abstract available
   
   

   
   Heart

10. WANG H, Li J, Hsi DH, Li W, et al
    Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy.
    Heart. 2025;111:933-940.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

11. KIRK BH, Palm P, Norgaard MW, Borregaard B, et al
    Prevention of readmission by intensified follow-up after transcatheter aortic valve implantation: Feasibility results of the PREMISS randomised controlled trial.
    Int J Cardiol. 2025 Sep 14:133894. doi: 10.1016/j.ijcard.2025.133894.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

12. CRISTIN L, Tastet L, Jhawar R, Rich AB, et al
    Sex-based Differences in Mitral Annular Disjunction Severity and Arrhythmic Risk in Mitral Valve Prolapse.
    J Am Soc Echocardiogr. 2025 Sep 15:S0894-7317(25)00517.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.